Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mFOLFOX6 Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer
NCT02226380Phase 2Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Oct 2013
- Primary completion
- Dec 2014
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of oxaliplatin, folinic acid and fluorouracil in gastric cancer (GC), sponsored by Peking Union Medical College Hospital. Primary endpoint: Overall Survival at 3 years. Status: unknown.
02
Drugs
oxaliplatinfolinic acidfluorouracil
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02226380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02226380.